Trevena Inc (TRVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRVN | BMY | AMGN | GILD | REGN |
| Company | Trevena Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4528 | 78.62 | 244.00 | 62.81 | 612.06 |
| High | 0.4800 | 79.00 | 246.00 | 63.13 | 613.15 |
| Low | 0.3724 | 78.12 | 242.88 | 61.85 | 602.52 |
| Last | 0.4181 | 78.96 | 245.37 | 63.08 | 612.49 |
| Change | -0.0419 | +1.27 | +2.28 | +0.50 | +5.10 |
| % Change | -9.11% | +1.63% | +0.94% | +0.80% | +0.84% |
| Volume | 22,389,701 | 12,372,200 | 4,527,600 | 9,207,700 | 818,200 |
| 20-Day Average Volume | 3,598,070 | 14,610,160 | 3,848,150 | 8,201,689 | 861,215 |
| Previous Close | 0.4600 | 77.69 | 243.09 | 62.58 | 607.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3890 | 75.45 | 243.74 | 61.70 | 606.50 |
| 20-Day Raw Stochastic | 73.18% | 99.45% | 55.76% | 71.31% | 46.84% |
| 20-Day Relative Strength | 55.71% | 62.35% | 53.09% | 54.96% | 47.54% |
| Weighted Alpha | -80.71 | +25.50 | +5.30 | -7.80 | +4.70 |
| Today's Opinion | 24% Sell | 88% Buy | 72% Buy | 16% Sell | 40% Sell |
| Previous Opinion | 24% Sell | 80% Buy | 40% Buy | 24% Sell | 56% Sell |
| Last Month's Opinion | 100% Sell | 96% Buy | 80% Buy | 24% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.22% since 06/16/22 | +8.73% since 06/16/22 | +6.35% since 06/16/22 | +9.29% since 06/16/22 | +10.01% since 06/16/22 |
| Low | 0.3724 on 06/24/22 | 72.67 on 06/17/22 | 229.49 on 06/17/22 | 57.29 on 06/17/22 | 561.71 on 06/17/22 |
| High | 0.4888 on 06/23/22 | 79.00 on 06/24/22 | 246.00 on 06/24/22 | 63.13 on 06/24/22 | 613.15 on 06/24/22 |
| 1-Month | |||||
| %Chg | +82.50% since 05/24/22 | +2.37% since 05/24/22 | -2.59% since 05/24/22 | -1.97% since 05/24/22 | -10.72% since 05/24/22 |
| Low | 0.2130 on 05/25/22 | 71.71 on 06/16/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 0.4888 on 06/23/22 | 79.00 on 06/24/22 | 257.97 on 06/01/22 | 65.46 on 05/26/22 | 699.63 on 05/25/22 |
| 3-Month | |||||
| %Chg | -17.87% since 03/24/22 | +9.05% since 03/24/22 | +3.59% since 03/24/22 | +6.66% since 03/24/22 | -9.90% since 03/24/22 |
| Low | 0.1805 on 05/11/22 | 71.71 on 06/16/22 | 227.32 on 05/02/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 0.6111 on 03/31/22 | 79.00 on 06/24/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 747.42 on 04/08/22 |
| 6-Month | |||||
| %Chg | -40.70% since 12/23/21 | +27.25% since 12/23/21 | +9.64% since 12/23/21 | -12.97% since 12/23/21 | -2.06% since 12/23/21 |
| Low | 0.1805 on 05/11/22 | 60.86 on 01/06/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 538.01 on 06/14/22 |
| High | 0.6900 on 12/27/21 | 79.00 on 06/24/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 747.42 on 04/08/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 69,204 | 168,110,880 | 131,076,648 | 79,122,064 | 66,479,048 |
| Shares Outstanding, K | 165,520 | 2,129,064 | 534,200 | 1,254,313 | 108,539 |
| Annual Sales | 570,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 16,071,700,000 |
| Annual Net Income | -51,590,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 8,075,300,000 |
| Last Quarter Sales | 20,000 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 2,965,100,000 |
| Last Quarter Net Income | -16,390,000 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 973,500,000 |
| 60-Month Beta | 2.44 | 0.49 | 0.57 | 0.37 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 05/11/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 11.49 on 05/04/22 |
| Latest Earnings Date | 08/11/22 | 07/27/22 | 08/02/22 | 08/04/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.06 | 13.77 | 8.54 | 7.73 |
